Thomas Unger
Unger, Thomas.
Unger, Th.
Unger, Thomas, 1950-
VIAF ID: 32244016 (Personal)
Permalink: http://viaf.org/viaf/32244016
Preferred Forms
- 100 0 _ ‡a Thomas Unger
- 200 _ | ‡a Unger ‡b Thomas
- 100 1 _ ‡a Unger, Th (sparse)
-
- 100 1 _ ‡a Unger, Th.
- 100 1 _ ‡a Unger, Thomas
- 100 1 _ ‡a Unger, Thomas
- 100 1 _ ‡a Unger, Thomas ‡d 1950-
-
-
4xx's: Alternate Name Forms (5)
5xx's: Related Names (7)
- 510 2 _ ‡a Charité - Universitätsmedizin Berlin ‡e Affiliation
- 510 2 _ ‡a Charité - Universitätsmedizin
- 510 2 _ ‡a Heidelberg, Univ
- 510 2 _ ‡a Humboldt-Universität zu Berlin ‡b Institut für Pharmakologie und Toxikologie ‡e Affiliation
- 510 2 _ ‡a Institut für Pharmakologie und Toxikologie
- 510 2 _ ‡a Symphonisches Orchester Berlin
- 510 2 _ ‡a Workshop Renal Protection by ACE Inhibitors, Faith or Truth? 1989 Fuschl
Works
Title | Sources |
---|---|
Aliskiren direkter Renin-Inhibitor zur Behandlung der Hypertonie ; 3 Tabellen | |
Angiotensin | |
Antithrombozytäre Strategien in der kardiovaskulären Akut- und Langzeittherapie | |
Blickpunkt Irbesartan | |
Blickpunkt Mibefradil | |
Habil.-Schr. - Heidelberg | |
Hypertonie 2000 24. wissenschaftliche Tagung der Deutschen Liga zur Bekämpfung des Hohen Blutdruckes/Deutsche Hypertonie-Gesellschaft, Heidelberg, 22. - 25. November 2000 ; extended abstracts | |
Kinins and converting enzyme inhibitors : [workshop held in Königstein, Federal Republic of Germany, June 7-9, 1989] | |
Klinik der Kälteagglutinationskrankheiten und neuere Ergebnisse über die Biochemie der mit den Kälteagglutininen korrespondierenden Antigene I/i | |
Konzert für Klavier und Orchester ; Nuancen : für Kammerensemble ; Gesänge des Abschieds : für Sopran, Flöte und Klavier | |
Lineare Optimierung : Modell, Lösung, Anwendung | |
Mehr als nur Blutdrucksenkung? Antihypertensive Therapie mit ACE-Hemmern ; Bericht über den Workshop Renal Protection by ACE-Inhibitors. Faith or Truth? Fuschl, Österreich, 12. - 13.10.1989 sowie das Symposium Antihypertensive Therapie mit ACE-Hemmern Prien, 13. - 14.10.1989 | |
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report | |
[Pathophysiological and clinical implications of AT | |
[Pathophysiology of essential hypertension. Recent findings | |
Patterns of antihypertensive drug utilization in primary care | |
Peptidergic and catecholaminergic mechanisms in central blood pressure control. | |
Perspective: A tale of two receptors. | |
The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League | |
Plasma renin and cardiovascular risk: what is the evidence for an association? | |
PLZF and the | |
PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice | |
Prävention und Therapie atherothrombotischer Erkrankungen Problemstellung, Fallbeispiele, Hintergrundinformationen | |
The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein | |
The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling | |
The promyelocytic leukemia zinc finger (PLZF) protein exerts neuroprotective effects in neuronal cells and is dysregulated in experimental stroke | |
Prorenin engages the | |
Renal outcome in equipotent antihypertensive treatment with telmisartan, ramipril and in combination in SHR-SP rats. | |
Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies | |
Renin-dependent water intake in hypovolemia. | |
Repression of c-fos and c-jun gene expression is not part of AT2 receptor coupled signal transduction | |
Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models | |
The role of olmesartan medoxomil in the management of hypertension | |
The role of the kidney in the aetiology of hypertension: renal transplantation studies in rats | |
Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availability. | |
Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage | |
Specialization of quadratic and symmetric bilinear forms | |
Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization | |
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia | |
Symposium on Neuropeptides and Blood Pressure Control (1984 : Heidelberg, Germany). Symposium on Neuropeptides and Blood Pressure Control ... c1985: | |
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk | |
Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension | |
Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation | |
Time-dependent apoptotic development and pro-apoptotic genes expression in rat heart after myocardial infarction. | |
Tissue Concentrations of Opioid Peptides in Rats do not Depend on Blood Pressure Height | |
Tissue converting enzyme inhibition and cardiovascular effects of converting enzyme inhibitors | |
Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components | |
Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction. | |
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat | |
Vascular remodeling in systemic hypertension. | |
Vasopressin in brain of spontaneously hypertensive rats. | |
Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex. | |
Vasopressin: mechanism of central cardiovascular action in conscious rats | |
Works. |